Status:
RECRUITING
Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis
Lead Sponsor:
University Hospital, Brest
Conditions:
Vestibular Neuritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Vestibular neuritis is a brutal and continuous dizzying syndrome of peripheral (vestibular) origin without cochlear or other associated involvement. Specifically, vestibular neuritis is inflammation o...
Eligibility Criteria
Inclusion
- adult patients,
- patient with vestibular neuritis defined by appearance of continuous rotating vertigo with nausea
- patient with spontaneous horizonto-rotating nystagmus beating towards the healthy ear
- patient with a postural deviation towards the affected ear;
- vestibular hyporeflexia measured at the caloric tests greater than 25%
- patient who has given free, enlighten and written consent
Exclusion
- patient with a history of vertigo of vestibular origin or with vertigo developing for more than 4 days
- patient with associated hearing loss or tinnitus
- patient with an motor ocular abnormality of central origin
- patient refusal or inability to consent
Key Trial Info
Start Date :
March 10 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 10 2027
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT04678167
Start Date
March 10 2021
End Date
March 10 2027
Last Update
July 21 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Brest
Brest, France, 29200
2
CH Pays de Morlaix
Morlaix, France, 29672
3
CH de Cornouaille Quimper
Quimper, France, 29107